Aeternum Health (AETN) Cost of Revenue (2010 - 2026)

Aeternum Health has disclosed Cost of Revenue across 15 years of filings, most recently posting $776.0 for Q1 2026.

• In Q1 2026, Cost of Revenue fell 15.84% year-over-year to $776.0; the TTM figure through Mar 2026 stood at $4245.0 (down 9.45% YoY), while the FY2025 annual figure was $4391.0, down 12.65% from the prior year.
• Cost of Revenue retreated to $776.0 in Q1 2026, from $900.0 in the prior quarter.
• Over the last five years, Cost of Revenue for AETN reached as high as $10886.0 in Q2 2023 and fell as low as $776.0 in Q1 2026.
• The 5-year median for Cost of Revenue is $1428.5 (2024), against an average of $3660.5.
• The widest YoY moves for Cost of Revenue: up 6.43% in 2023, down 23.56% in 2023.
• A 5-year view of Cost of Revenue shows it stood at $1664.0 in 2022, then climbed by 6.43% to $1771.0 in 2023, then sank by 43.31% to $1004.0 in 2024, then dropped by 10.36% to $900.0 in 2025, then declined by 13.78% to $776.0 in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $776.0, $900.0, and $1435.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.